INDV (INDV) Stock Price & Analysis
INDV (INDV) rose 0.00% to USD 40.53 as of July 25, 2026 at 03:40 UTC, according to Nexqual real-time market data.
INDV last closed at USD 40.53; the session ranged USD 40.08–40.95 on volume of 644,099 shares. Market capitalization is —, with a 52-week range of USD 16.69–42.81 (NMS). Source: Nexqual, July 25, 2026 at 03:40 UTC.
Key Statistics (as of July 25, 2026 at 03:40 UTC)
| Price | USD 40.53 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 40.53 |
| Open | USD 40.53 |
| Day Range | USD 40.08 – 40.95 |
| 52-Week Range | USD 16.69 – 42.81 |
| Volume | 644,099 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (INDV)
Nexqual's technical model rates INDV "BUY" based on 4 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 03:40 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 56.05 (neutral) |
| vs SMA50 | Above (USD 38.82) |
| MACD | 0.42 (positive) |
From INDV's Latest SEC 10-K Filing (filed 2026-02-26)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BTSG | BrightSpring Health Services, I | USD 72.91 | ▲ 4.55% |
| MLYS | Mineralys Therapeutics, Inc. | USD 26.71 | ▼ 1.11% |
| TVTX | Travere Therapeutics, Inc. | USD 57.36 | ▲ 1.96% |
| ELVN | Enliven Therapeutics, Inc. | USD 52.95 | ▲ 0.19% |
| SYRE | Spyre Therapeutics, Inc. | USD 102.13 | ▲ 2.98% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:40 UTC. This page is informational and not investment advice.